SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000875320-14-000026
Filing Date
2014-05-05
Accepted
2014-05-05 16:07:48
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a2014q110-q.htm 10-Q 1016510
2 EX-31.1 a2014q110-q_exhibit31122.htm EX-31.1 14547
3 EX-31.2 a2014q110-q_exhibit31222.htm EX-31.2 14381
4 EX-32.1 a2014q110-q_exhibit32122.htm EX-32.1 11773
  Complete submission text file 0000875320-14-000026.txt   7178275

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT vrtx-20140331.xml EX-101.INS 1156702
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrtx-20140331.xsd EX-101.SCH 53263
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrtx-20140331_cal.xml EX-101.CAL 81898
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrtx-20140331_def.xml EX-101.DEF 172004
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrtx-20140331_lab.xml EX-101.LAB 620059
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrtx-20140331_pre.xml EX-101.PRE 315825
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19319 | Film No.: 14813484
SIC: 2834 Pharmaceutical Preparations